On Friday, ImmunoGen, Inc. (NASDAQ:IMGN)’s shares surged 1.93% to $10.02, as a biotechnology company, declared that the Company will host a conference call at 8:00 a.m. ET on Friday, April 24, 2015, to talk about ImmunoGen’s financial results for the three-month period ended March 31, 2015, the third quarter of its 2015 fiscal year. Administration will also provide an update on the Company and the financial guidance.
ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. The company offers Kadcyla, an antibody-drug conjugate for the treatment of HER2-positive metastatic breast cancer.
Arch Coal Inc. (NYSE:ACI)’s shares gained 1.90% to $1.07, during the last trading session on Friday, as Arch Coal will talk about its first quarter 2015 financial results in a conference call that will be webcast live on Tuesday, April 21 at 10:00 a.m. Eastern time. Participating on the call will be Arch President and Chief Executive Officer John W. Eaves, Executive Vice President and Chief Operating Officer Paul A. Lang and Senior Vice President and Chief Financial Officer John T. Drexler.
Arch Coal, Inc. produces and sells thermal and metallurgical coal from surface and underground mines located in the United States. As of December 31, 2014, it operated or contracted out the operation of 16 mines; and owned or controlled about 5.1 billion tons of proven and probable recoverable reserves.
At the end of Friday’s trade, Pinnacle West Capital Corporation (NYSE:PNW)’s shares gained 1.87% to $63.78, as last week Tell Utilities Solar Won’t Be Killed (TUSK) issued a news release asserting all sorts of things about last week’s APS “Grid Access Charge” filing that unfortunately is, at best, erroneous and intentionally misleading, said APS.
APS, Arizona’s largest and longest-serving electricity utility, serves nearly 1.2 million customers in 11 of the state’s 15 counties. With headquarters in Phoenix, APS is the largest principal partner of Pinnacle West Capital Corp. (PNW).
Pinnacle West Capital Corporation, through its partner, Arizona Public Service Company, provides retail and wholesale electric services primarily in the State of Arizona. It generates, transmits, and distributes electricity using coal, nuclear, gas, oil, and solar resources. The company serves about 1.2 million customers. It owns or leases about 6,426 megawatts of regulated generation capacity. The company was founded in 1920 and is headquartered in Phoenix, Arizona.
Finally, Bristol-Myers Squibb Company (NYSE:BMY), ended its Friday’s trading session with 1.86% gain, and closed at $64.64, after Bristol-Myers declared that it has accomplished the formerly declared planned attainment of Flexus Biosciences, Inc.
The transaction comprised full rights to F001287, Flexus’ lead preclinical, small-molecule IDO1-inhibitor targeted for IND filing in the second half of 2015 and an IDO/TDO discovery program that comprises its IDO-selective, IDO/TDO dual and TDO-selective compound libraries. A newly formed entity established by the current shareholders of Flexus will retain, from and after the closing, all non-IDO/TDO assets of Flexus counting those related to Flexus’ Phase 1 FLT3 and CDK4/6 inhibitor, its earlier stage small-molecule Treg cancer immunotherapy programs, and its current personnel and facilities.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, counting virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
